Optomed’s fun­dus cam­era reward­ed the AI Use Case of the Year in the health­care cat­e­go­ry

Optomed’s AI-pow­ered Auro­ra AEYE fun­dus cam­era was recog­nised as the AI Use Case of the Year in the health­care cat­e­go­ry at the AI Gala on 23 Octo­ber 2024.

In the health­care cat­e­go­ry, the goal was to find an AI inno­va­tion that has improved the qual­i­ty of care, effi­cien­cy, or patient qual­i­ty of life. The jury, led by Ris­to Siilas­maa, select­ed the top three can­di­dates in ten dif­fer­ent cat­e­gories from among hun­dreds of nom­i­nees. In addi­tion to Optomed, the top three includ­ed CGI, HUS, Plan­meca’s AI Head Analy­sis, and Kus­tan­nus Oy Duodec­im.

Optomed’s Auro­ra AEYE is a prod­uct that can screen dia­bet­ic patients for blind­ing eye dis­ease (dia­bet­ic retinopa­thy) and was the first hand­held cam­era in the U.S. to receive reg­u­la­to­ry approval and a sales per­mit in May 2024. By inte­grat­ing AI, the cam­era enables access to eye screen­ings and treat­ment for a much broad­er patient pop­u­la­tion, as the screen­ings can be brought clos­er to patients, for exam­ple, in pri­ma­ry health­care, home care, or phar­ma­cies.

The AI Gala, organ­ised by AI Fin­land and its part­ners, was held for the first time this year. The AI Fin­land net­work was estab­lished in March 2024 to bring togeth­er Finnish com­pa­nies and oth­er enti­ties inter­est­ed in arti­fi­cial intel­li­gence. The network’s goal is to increase the adop­tion and devel­op­ment of arti­fi­cial intel­li­gence in Fin­land.

Source: Healthtech Fin­land